Yield10 Bioscience, Inc. (NASDAQ:YTEN) has its shares plummet by -90.4% or $1.6 from its all-time high of $1.77. The drop in the price of the shares saw it stand at $0.17 per share. YTEN has been trading at a low of $0.11 over the past one year but it surged by 54.55% or $0.06 to reach the $0.17 mark. Following the massive rise in stock price, YTEN received more attention from investors and analysts. On Sunday, the stock dipped by -8.49%, which caused investors and analysts to worry about it. Following the plunge in price, the YTEN beta stands at 2.98, implying that its volatility level has gone up by -1.98 ahead of the general market. A look at the stock’s 200-day moving average shows that it is -76.99% below while its 50-day moving average shows that it is currently -38.25% below. Compared to 15.66% average daily volatility of past month, the stock’s average volatility for this week has decreased by -4.1 as the volatility level currently stands at 11.56%.
Over the past seven days, the stock has witnessed a price surge by 3.95%. This massive rise in stock price has caught the attention of both investors and market traders. The stock has performed poorly over the past 52 weeks, dropping by -76.85% during that time frame and is now down by -79.08% since this point this year. YTEN has surged by 39.55% over the past 30 days, with its equity price losing% of its value over the past ninety days. These figures add up to see the stock record a shortfall of -82.08% over the past six months.
The stock’s technical analysis reveals that its 14-day Relative Strength Index (RSI) is currently in a neutral position as it was able to attain 44.87 points. The trading volume now standing at 6594832 shares. The increase of 4394832 shares in trading volume shows that traders and investors have shown more interest in the stock over the past few weeks. During that trading session, the average trading volume of YTEN was 2200000 shares, which is more than 3 times higher than its usual trading volume.
The stock is currently neutral as its Stochastic Oscillator (%D) is at 77.78%, which implies that a stability in price will be experienced for a while. Its shares P/S ratio is below the industry average and below the wider market, as BBBY’s P/S ratio currently stands at 0.19. The stock’s estimated price-earnings (P/E) multiple is 8.81 which is also above the 12-month price-earnings (P/E) which stands at 0. Bed Bath & Beyond Inc. has experienced a fall in its earnings, recording an decrease rate of -17.2% in each quarter over the past five years.
The stock has an average rating of 2.7 which means that it has been rated as a Hold by most analysts. The stock is being covered by 15 analysts who gave a consensus recommendation of 2.7 which implies that it is currently in a neutral situation. Reuters looked into analysts covering Bed Bath & Beyond Inc., and 9 of them believe that the stock is a Hold at the moment. 6 of the analysts rated it as a Buy or a Strong Buy while the remaining analysts (1) rated it as a sell at the moment.